Genome-Wide Supported Risk Variants in MIR137, CACNA1C, CSMD1, DRD2, and GRM3 Contribute to Schizophrenia Susceptibility in Pakistani Population

키워드

참고문헌 (34)

1. The International Schizophrenia Consortium, "Common polygenic variation contributes to risk of schizophrenia and bipolar disorder", Nature, 460, pp.748~752 (2009)
2. Schizophrenia Psychiatric Genome-Wide Association Study (GWAS) Consortium, "Genome-wide association study identifies five new schizophrenia loci", Nat Genet, 43, pp.969~976 (2011)
3. Schizophrenia Working Group of the Psychiatric Genomics Consortium, "Biological insights from 108 schizophrenia-associated genetic loci", Nature, 511, pp.421~427 (2014)
4. Bergen SE, "Genome-wide association studies of schizophrenia: does bigger lead to better results?", Curr Opin Psychiatry, 25, pp.76~82 (2012)
5. Szulwach KE, "Cross talk between microRNA and epigenetic regulation in adult neurogenesis", J Cell Biol, 189, pp.127~141 (2010)
6. Whalley HC, "Impact of a microRNA MIR137 susceptibility variant on brain function in people at high genetic risk of schizophrenia or bipolar disorder", Neuropsychopharmacology, 37, pp.2720~2729 (2012)
7. Green MJ, "Genome-wide supported variant MIR137 and severe negative symptoms predict membership of an impaired cognitive subtype of schizophrenia", Mol Psychiatry, 18, pp.774~780 (2013)
8. Hamshere ML, "Genome-wide significant associations in schizophrenia to ITIH3", 4, CACNA1C and SDCCAG8, and extensive replication of associations reported by the Schizophrenia PGC, 2013, pp.18, 708~712
9. Ferreira MA, "Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder", Nat Genet, 40, pp.1056~1058 (2008)
10. Green EK, "The bipolar disorder risk allele at CACNA1C also confers risk of recurrent major depression and of schizophrenia", Mol Psychiatry, 15, pp.1016~1022 (2010)
11. Bigos KL, "Genetic variation in CACNA1C affects brain circuitries related to mental illness", Arch Gen Psychiatry, 67, pp.939~945 (2010)
12. Guan F, "MIR137 gene and target gene CACNA1C of miR-137 contribute to schizophrenia susceptibility in Han Chinese", Schizophr Res, 152, pp.97~104 (2014)
13. Shimizu A, "A novel giant gene CSMD3 encoding a protein with CUB and sushi multiple domains: a candidate gene for benign adult familial myoclonic epilepsy on human chromosome 8q23.3-q24.1", Biochem Biophys Res Commun, 309, pp.143~154 (2003)
14. Xu W, "Genome-wide association study of bipolar disorder in Canadian and UK populations corroborates disease loci including SYNE1 and CSMD1", BMC Med Genet, 15, pp.2~
15. Donohoe G, "Neuropsychological effects of the CSMD1 genome-wide associated schizophrenia risk variant rs10503253", Genes Brain Behav, 12, pp.203~209 (2013)
16. Koiliari E, "The CSMD1 genome-wide associated schizophrenia risk variant rs10503253 affects general cognitive ability and executive function in healthy males", Schizophr Res, 154, pp.42~47 (2014)
17. Egan MF, "Variation in GRM3 affects cognition, prefrontal glutamate, and risk for schizophrenia", Proc Natl Acad Sci USA, 101, pp.12604~12609 (2004)
18. Mössner R, "Further evidence for a functional role of the glutamate receptor gene GRM3 in schizophrenia", Eur Neuropsychopharmacol, 18, pp.768~772 (2008)
19. O’Brien NL, "The functional GRM3 Kozak sequence variant rs148754219 affects the risk of schizophrenia and alcohol dependence as well as bipolar disorder", Psychiatr Genet, 24, pp.277~278 (2014)
20. Colizzi M, "Interaction between functional genetic variation of drd2 and cannabis use on risk of psychosis", Schizophr Bull, 41, pp.1171~1182 (2015)
21. Zheng C, "Rs1076560, a functional variant of the dopamine D2 receptor gene, confers risk of schizophrenia in Han Chinese", Neurosci Lett, 518, pp.41~44 (2012)
22. Nyegaard M, "CACNA1C(rs1006737)is associated with schizophrenia", Mol Psychiatry, 15, pp.119~121 (2010)
23. Erk S, "Brain function in carriers of a genome-wide supported bipolar disorder variant", Arch Gen Psychiatry, 67, pp.803~811 (2010)
24. Soeiro-de-Souza MG, "The CACNA1C risk allele selectively impacts on executive function in bipolar type I disorder", Acta Psychiatr Scand, 128, pp.362~269 (2013)
25. Erk S, "Replication of brain function effects of a genome-wide supported psychiatric risk variant in the CACNA1C gene and new multi-locus effects", Neuroimage, 94, pp.147~154 (2014)
26. Krug A, "A genome-wide supported variant in CACNA1C influences hippocampal activation during episodic memory encoding and retrieval", Eur Arch Psychiatry Clin Neurosci, 264, pp.103~110 (2014)
27. Zhang Q, "The effects of CACNA1C gene polymorphism on spatial working memory in both healthy controls and patients with schizophrenia or bipolar disorder", Neuropsychopharmacology, 37, pp.677~684 (2012)
28. Hori H, "Effects of the CACNA1C risk allele on neurocognition in patients with schizophrenia and healthy individuals", Sci Rep, 2, pp.634~ (2012)
29. Frank MJ, "Genetic contributions to avoidance-based decisions : striatal D2 receptor polymorphisms", Neuroscience, 164, pp.131~140 (2009)
30. Bertolino A, "Functional variants of the dopamine receptor D2 gene modulate prefronto-striatal phenotypes in schizophrenia", Brain, 132, pp.417~425 (2009)
31. Cohen OS, "A splicing-regulatory polymorphism in DRD2 disrupts ZRANB2 binding, impairs cognitive functioning and increases risk for schizophrenia in six Han Chinese samples", Mol Psychiatry, 21, pp.975~982 (2016)
32. Yuan J, "Lack of association between microRNA-137 SNP rs1625579 and schizophrenia in a replication study of Han Chinese", Mol Genet Genomics, 290, pp.297~301 (2015)
33. Rose EJ, "The miR-137 schizophrenia susceptibility variant rs1625579 does not predict variability in brain volume in a sample of schizophrenic patients and healthy individuals", Am J Med Genet B Neuropsychiatr Genet, 165B, pp.467~471 (2014)
34. Wang S, "Association of microRNA137 gene polymorphisms with age at onset and positive symptoms of schizophrenia in a Han Chinese population", Int J Psychiatry Med, 47, pp.153~168 (2014)

관련 논문AI추천